Historical record - last NADAC effective date: 9/23/2015

Product Information

NEVIRAPINE 200 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.1556 per EA under NDC 65162020906. Its NADAC has been published 97 times since Nov 28, 2013.

FDA first approved this application on May 22, 2012.

NEVIRAPINE 200 MG TABLET

Nevirapine
$0.1556per EA

Strength

200 mg/1

NDC

65162020906

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2015

Active Ingredients

NEVIRAPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA078195

FDA Approved

5/22/2012

On Market Since

4/30/2014

Pharmacological Classes

Cytochrome P450 2B6 Inducers
Cytochrome P450 3A Inducers
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for NEVIRAPINE 200 MG TABLET has been published 97 times since Nov 28, 2013, and over the history we have for it it has declined 15.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1556 per EA
All-time high$0.2389 (Feb 12, 2014)
All-time low$0.1417 (Aug 19, 2015)
Median price$0.1576
Average price$0.1610
Largest weekly change+41.7% (Jan 22, 2014)
Weeks tracked97
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-15.6%

Last surveyed Sep 30, 2015 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of NEVIRAPINE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NEVIRAPINE 200 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.1556 per EA (NDC 65162020906), effective Sep 30, 2015.

How has the price of NEVIRAPINE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for NEVIRAPINE 200 MG TABLET has declined 15.6%. It has been tracked across 97 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NEVIRAPINE 200 MG TABLET?

Since Nov 28, 2013, the NADAC for NEVIRAPINE 200 MG TABLET has ranged from a low of $0.1417 (Aug 19, 2015) to a high of $0.2389 (Feb 12, 2014), with a median of $0.1576 per EA.

Are there cheaper alternatives to NEVIRAPINE 200 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NEVIRAPINE 200 MG TABLET, is $0.1314 per EA — about 16% below NEVIRAPINE 200 MG TABLET.

Who manufactures NEVIRAPINE 200 MG TABLET?

NEVIRAPINE 200 MG TABLET (NDC 65162020906) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.